The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Targeted Chemotherapy Drugs Market Research Report 2025
Synopsis
Targeted Chemotherapy Drugs are a class of medications designed to specifically target and attack cancer cells without affecting normal cells. They work by identifying and interfering with specific molecules involved in the growth, progression, and spread of cancer. These drugs can be considered a form of precision medicine, as they aim to match a patient’s individual genetic profile with an appropriate targeted therapy.
The global Targeted Chemotherapy Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Targeted Chemotherapy Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Targeted Chemotherapy Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Targeted Chemotherapy Drugs include Roche, Celgene, Bristol-Myers Squibb, Takeda, Seekyo, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Targeted Chemotherapy Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Targeted Chemotherapy Drugs.
The Targeted Chemotherapy Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Targeted Chemotherapy Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Targeted Chemotherapy Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Roche
Celgene
Bristol-Myers Squibb
Takeda
Seekyo
Segment by Type
Monoclonal Antibodies (MABs)
Cancer Growth Blockers
Angiogenesis Inhibitors
PARP Inhibitors
Segment by Application
Breast Cancer Treatment
Lung Cancer Treatment
Gastric Cancer Treatment
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Targeted Chemotherapy Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Targeted Chemotherapy Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Targeted Chemotherapy Drugs are a class of medications designed to specifically target and attack cancer cells without affecting normal cells. They work by identifying and interfering with specific molecules involved in the growth, progression, and spread of cancer. These drugs can be considered a form of precision medicine, as they aim to match a patient’s individual genetic profile with an appropriate targeted therapy.
The global Targeted Chemotherapy Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Targeted Chemotherapy Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Targeted Chemotherapy Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Targeted Chemotherapy Drugs include Roche, Celgene, Bristol-Myers Squibb, Takeda, Seekyo, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Targeted Chemotherapy Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Targeted Chemotherapy Drugs.
The Targeted Chemotherapy Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Targeted Chemotherapy Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Targeted Chemotherapy Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Roche
Celgene
Bristol-Myers Squibb
Takeda
Seekyo
Segment by Type
Monoclonal Antibodies (MABs)
Cancer Growth Blockers
Angiogenesis Inhibitors
PARP Inhibitors
Segment by Application
Breast Cancer Treatment
Lung Cancer Treatment
Gastric Cancer Treatment
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Targeted Chemotherapy Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Targeted Chemotherapy Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Targeted Chemotherapy Drugs Market Overview
1.1 Product Definition
1.2 Targeted Chemotherapy Drugs by Type
1.2.1 Global Targeted Chemotherapy Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Monoclonal Antibodies (MABs)
1.2.3 Cancer Growth Blockers
1.2.4 Angiogenesis Inhibitors
1.2.5 PARP Inhibitors
1.3 Targeted Chemotherapy Drugs by Application
1.3.1 Global Targeted Chemotherapy Drugs Market Value by Application (2024-2030)
1.3.2 Breast Cancer Treatment
1.3.3 Lung Cancer Treatment
1.3.4 Gastric Cancer Treatment
1.3.5 Others
1.4 Global Targeted Chemotherapy Drugs Market Size Estimates and Forecasts
1.4.1 Global Targeted Chemotherapy Drugs Revenue 2019-2030
1.4.2 Global Targeted Chemotherapy Drugs Sales 2019-2030
1.4.3 Global Targeted Chemotherapy Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Targeted Chemotherapy Drugs Market Competition by Manufacturers
2.1 Global Targeted Chemotherapy Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Targeted Chemotherapy Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Targeted Chemotherapy Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Targeted Chemotherapy Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Targeted Chemotherapy Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Targeted Chemotherapy Drugs, Product Type & Application
2.7 Global Key Manufacturers of Targeted Chemotherapy Drugs, Date of Enter into This Industry
2.8 Global Targeted Chemotherapy Drugs Market Competitive Situation and Trends
2.8.1 Global Targeted Chemotherapy Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Targeted Chemotherapy Drugs Players Market Share by Revenue
2.8.3 Global Targeted Chemotherapy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Targeted Chemotherapy Drugs Market Scenario by Region
3.1 Global Targeted Chemotherapy Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Targeted Chemotherapy Drugs Sales by Region: 2019-2030
3.2.1 Global Targeted Chemotherapy Drugs Sales by Region: 2019-2024
3.2.2 Global Targeted Chemotherapy Drugs Sales by Region: 2025-2030
3.3 Global Targeted Chemotherapy Drugs Revenue by Region: 2019-2030
3.3.1 Global Targeted Chemotherapy Drugs Revenue by Region: 2019-2024
3.3.2 Global Targeted Chemotherapy Drugs Revenue by Region: 2025-2030
3.4 North America Targeted Chemotherapy Drugs Market Facts & Figures by Country
3.4.1 North America Targeted Chemotherapy Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Targeted Chemotherapy Drugs Sales by Country (2019-2030)
3.4.3 North America Targeted Chemotherapy Drugs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Targeted Chemotherapy Drugs Market Facts & Figures by Country
3.5.1 Europe Targeted Chemotherapy Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Targeted Chemotherapy Drugs Sales by Country (2019-2030)
3.5.3 Europe Targeted Chemotherapy Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Targeted Chemotherapy Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Targeted Chemotherapy Drugs Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Targeted Chemotherapy Drugs Sales by Region (2019-2030)
3.6.3 Asia Pacific Targeted Chemotherapy Drugs Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Targeted Chemotherapy Drugs Market Facts & Figures by Country
3.7.1 Latin America Targeted Chemotherapy Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Targeted Chemotherapy Drugs Sales by Country (2019-2030)
3.7.3 Latin America Targeted Chemotherapy Drugs Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Targeted Chemotherapy Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Targeted Chemotherapy Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Targeted Chemotherapy Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Targeted Chemotherapy Drugs Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Targeted Chemotherapy Drugs Sales by Type (2019-2030)
4.1.1 Global Targeted Chemotherapy Drugs Sales by Type (2019-2024)
4.1.2 Global Targeted Chemotherapy Drugs Sales by Type (2025-2030)
4.1.3 Global Targeted Chemotherapy Drugs Sales Market Share by Type (2019-2030)
4.2 Global Targeted Chemotherapy Drugs Revenue by Type (2019-2030)
4.2.1 Global Targeted Chemotherapy Drugs Revenue by Type (2019-2024)
4.2.2 Global Targeted Chemotherapy Drugs Revenue by Type (2025-2030)
4.2.3 Global Targeted Chemotherapy Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Targeted Chemotherapy Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Targeted Chemotherapy Drugs Sales by Application (2019-2030)
5.1.1 Global Targeted Chemotherapy Drugs Sales by Application (2019-2024)
5.1.2 Global Targeted Chemotherapy Drugs Sales by Application (2025-2030)
5.1.3 Global Targeted Chemotherapy Drugs Sales Market Share by Application (2019-2030)
5.2 Global Targeted Chemotherapy Drugs Revenue by Application (2019-2030)
5.2.1 Global Targeted Chemotherapy Drugs Revenue by Application (2019-2024)
5.2.2 Global Targeted Chemotherapy Drugs Revenue by Application (2025-2030)
5.2.3 Global Targeted Chemotherapy Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Targeted Chemotherapy Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Targeted Chemotherapy Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Roche Targeted Chemotherapy Drugs Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Celgene
6.2.1 Celgene Company Information
6.2.2 Celgene Description and Business Overview
6.2.3 Celgene Targeted Chemotherapy Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Celgene Targeted Chemotherapy Drugs Product Portfolio
6.2.5 Celgene Recent Developments/Updates
6.3 Bristol-Myers Squibb
6.3.1 Bristol-Myers Squibb Company Information
6.3.2 Bristol-Myers Squibb Description and Business Overview
6.3.3 Bristol-Myers Squibb Targeted Chemotherapy Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bristol-Myers Squibb Targeted Chemotherapy Drugs Product Portfolio
6.3.5 Bristol-Myers Squibb Recent Developments/Updates
6.4 Takeda
6.4.1 Takeda Company Information
6.4.2 Takeda Description and Business Overview
6.4.3 Takeda Targeted Chemotherapy Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Takeda Targeted Chemotherapy Drugs Product Portfolio
6.4.5 Takeda Recent Developments/Updates
6.5 Seekyo
6.5.1 Seekyo Company Information
6.5.2 Seekyo Description and Business Overview
6.5.3 Seekyo Targeted Chemotherapy Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Seekyo Targeted Chemotherapy Drugs Product Portfolio
6.5.5 Seekyo Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Targeted Chemotherapy Drugs Industry Chain Analysis
7.2 Targeted Chemotherapy Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Targeted Chemotherapy Drugs Production Mode & Process
7.4 Targeted Chemotherapy Drugs Sales and Marketing
7.4.1 Targeted Chemotherapy Drugs Sales Channels
7.4.2 Targeted Chemotherapy Drugs Distributors
7.5 Targeted Chemotherapy Drugs Customers
8 Targeted Chemotherapy Drugs Market Dynamics
8.1 Targeted Chemotherapy Drugs Industry Trends
8.2 Targeted Chemotherapy Drugs Market Drivers
8.3 Targeted Chemotherapy Drugs Market Challenges
8.4 Targeted Chemotherapy Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Targeted Chemotherapy Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Targeted Chemotherapy Drugs Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Targeted Chemotherapy Drugs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Targeted Chemotherapy Drugs Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Targeted Chemotherapy Drugs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Targeted Chemotherapy Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Targeted Chemotherapy Drugs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Targeted Chemotherapy Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Targeted Chemotherapy Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Targeted Chemotherapy Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Targeted Chemotherapy Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Targeted Chemotherapy Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Targeted Chemotherapy Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Chemotherapy Drugs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Targeted Chemotherapy Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Targeted Chemotherapy Drugs Sales by Region (2019-2024) & (K Units)
Table 18. Global Targeted Chemotherapy Drugs Sales Market Share by Region (2019-2024)
Table 19. Global Targeted Chemotherapy Drugs Sales by Region (2025-2030) & (K Units)
Table 20. Global Targeted Chemotherapy Drugs Sales Market Share by Region (2025-2030)
Table 21. Global Targeted Chemotherapy Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Targeted Chemotherapy Drugs Revenue Market Share by Region (2019-2024)
Table 23. Global Targeted Chemotherapy Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Targeted Chemotherapy Drugs Revenue Market Share by Region (2025-2030)
Table 25. North America Targeted Chemotherapy Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Targeted Chemotherapy Drugs Sales by Country (2019-2024) & (K Units)
Table 27. North America Targeted Chemotherapy Drugs Sales by Country (2025-2030) & (K Units)
Table 28. North America Targeted Chemotherapy Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Targeted Chemotherapy Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Targeted Chemotherapy Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Targeted Chemotherapy Drugs Sales by Country (2019-2024) & (K Units)
Table 32. Europe Targeted Chemotherapy Drugs Sales by Country (2025-2030) & (K Units)
Table 33. Europe Targeted Chemotherapy Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Targeted Chemotherapy Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Targeted Chemotherapy Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Targeted Chemotherapy Drugs Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Targeted Chemotherapy Drugs Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Targeted Chemotherapy Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Targeted Chemotherapy Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Targeted Chemotherapy Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Targeted Chemotherapy Drugs Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Targeted Chemotherapy Drugs Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Targeted Chemotherapy Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Targeted Chemotherapy Drugs Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Targeted Chemotherapy Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Targeted Chemotherapy Drugs Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Targeted Chemotherapy Drugs Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Targeted Chemotherapy Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Targeted Chemotherapy Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Targeted Chemotherapy Drugs Sales (K Units) by Type (2019-2024)
Table 51. Global Targeted Chemotherapy Drugs Sales (K Units) by Type (2025-2030)
Table 52. Global Targeted Chemotherapy Drugs Sales Market Share by Type (2019-2024)
Table 53. Global Targeted Chemotherapy Drugs Sales Market Share by Type (2025-2030)
Table 54. Global Targeted Chemotherapy Drugs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Targeted Chemotherapy Drugs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Targeted Chemotherapy Drugs Revenue Market Share by Type (2019-2024)
Table 57. Global Targeted Chemotherapy Drugs Revenue Market Share by Type (2025-2030)
Table 58. Global Targeted Chemotherapy Drugs Price (US$/Unit) by Type (2019-2024)
Table 59. Global Targeted Chemotherapy Drugs Price (US$/Unit) by Type (2025-2030)
Table 60. Global Targeted Chemotherapy Drugs Sales (K Units) by Application (2019-2024)
Table 61. Global Targeted Chemotherapy Drugs Sales (K Units) by Application (2025-2030)
Table 62. Global Targeted Chemotherapy Drugs Sales Market Share by Application (2019-2024)
Table 63. Global Targeted Chemotherapy Drugs Sales Market Share by Application (2025-2030)
Table 64. Global Targeted Chemotherapy Drugs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Targeted Chemotherapy Drugs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Targeted Chemotherapy Drugs Revenue Market Share by Application (2019-2024)
Table 67. Global Targeted Chemotherapy Drugs Revenue Market Share by Application (2025-2030)
Table 68. Global Targeted Chemotherapy Drugs Price (US$/Unit) by Application (2019-2024)
Table 69. Global Targeted Chemotherapy Drugs Price (US$/Unit) by Application (2025-2030)
Table 70. Roche Company Information
Table 71. Roche Description and Business Overview
Table 72. Roche Targeted Chemotherapy Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Roche Targeted Chemotherapy Drugs Product
Table 74. Roche Recent Developments/Updates
Table 75. Celgene Company Information
Table 76. Celgene Description and Business Overview
Table 77. Celgene Targeted Chemotherapy Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Celgene Targeted Chemotherapy Drugs Product
Table 79. Celgene Recent Developments/Updates
Table 80. Bristol-Myers Squibb Company Information
Table 81. Bristol-Myers Squibb Description and Business Overview
Table 82. Bristol-Myers Squibb Targeted Chemotherapy Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Bristol-Myers Squibb Targeted Chemotherapy Drugs Product
Table 84. Bristol-Myers Squibb Recent Developments/Updates
Table 85. Takeda Company Information
Table 86. Takeda Description and Business Overview
Table 87. Takeda Targeted Chemotherapy Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Takeda Targeted Chemotherapy Drugs Product
Table 89. Takeda Recent Developments/Updates
Table 90. Seekyo Company Information
Table 91. Seekyo Description and Business Overview
Table 92. Seekyo Targeted Chemotherapy Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Seekyo Targeted Chemotherapy Drugs Product
Table 94. Seekyo Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Targeted Chemotherapy Drugs Distributors List
Table 98. Targeted Chemotherapy Drugs Customers List
Table 99. Targeted Chemotherapy Drugs Market Trends
Table 100. Targeted Chemotherapy Drugs Market Drivers
Table 101. Targeted Chemotherapy Drugs Market Challenges
Table 102. Targeted Chemotherapy Drugs Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Product Picture of Targeted Chemotherapy Drugs
Figure 2. Global Targeted Chemotherapy Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Targeted Chemotherapy Drugs Market Share by Type: 2023 & 2030
Figure 4. Monoclonal Antibodies (MABs) Product Picture
Figure 5. Cancer Growth Blockers Product Picture
Figure 6. Angiogenesis Inhibitors Product Picture
Figure 7. PARP Inhibitors Product Picture
Figure 8. Global Targeted Chemotherapy Drugs Market Value by Application (2024-2030) & (US$ Million)
Figure 9. Global Targeted Chemotherapy Drugs Market Share by Application: 2023 & 2030
Figure 10. Breast Cancer Treatment
Figure 11. Lung Cancer Treatment
Figure 12. Gastric Cancer Treatment
Figure 13. Others
Figure 14. Global Targeted Chemotherapy Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Targeted Chemotherapy Drugs Market Size (2019-2030) & (US$ Million)
Figure 16. Global Targeted Chemotherapy Drugs Sales (2019-2030) & (K Units)
Figure 17. Global Targeted Chemotherapy Drugs Average Price (US$/Unit) & (2019-2030)
Figure 18. Targeted Chemotherapy Drugs Report Years Considered
Figure 19. Targeted Chemotherapy Drugs Sales Share by Manufacturers in 2023
Figure 20. Global Targeted Chemotherapy Drugs Revenue Share by Manufacturers in 2023
Figure 21. Global 5 and 10 Largest Targeted Chemotherapy Drugs Players: Market Share by Revenue in Targeted Chemotherapy Drugs in 2023
Figure 22. Targeted Chemotherapy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 23. Global Targeted Chemotherapy Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America Targeted Chemotherapy Drugs Sales Market Share by Country (2019-2030)
Figure 25. North America Targeted Chemotherapy Drugs Revenue Market Share by Country (2019-2030)
Figure 26. United States Targeted Chemotherapy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada Targeted Chemotherapy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe Targeted Chemotherapy Drugs Sales Market Share by Country (2019-2030)
Figure 29. Europe Targeted Chemotherapy Drugs Revenue Market Share by Country (2019-2030)
Figure 30. Germany Targeted Chemotherapy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Targeted Chemotherapy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Targeted Chemotherapy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Targeted Chemotherapy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia Targeted Chemotherapy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Targeted Chemotherapy Drugs Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific Targeted Chemotherapy Drugs Revenue Market Share by Region (2019-2030)
Figure 37. China Targeted Chemotherapy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan Targeted Chemotherapy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea Targeted Chemotherapy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India Targeted Chemotherapy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Targeted Chemotherapy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. China Taiwan Targeted Chemotherapy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Southeast Asia Targeted Chemotherapy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Targeted Chemotherapy Drugs Sales Market Share by Country (2019-2030)
Figure 45. Mexico Targeted Chemotherapy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Targeted Chemotherapy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Targeted Chemotherapy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Colombia Targeted Chemotherapy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East and Africa Targeted Chemotherapy Drugs Sales Market Share by Country (2019-2030)
Figure 50. Middle East and Africa Targeted Chemotherapy Drugs Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Targeted Chemotherapy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Targeted Chemotherapy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Targeted Chemotherapy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Targeted Chemotherapy Drugs by Type (2019-2030)
Figure 55. Global Revenue Market Share of Targeted Chemotherapy Drugs by Type (2019-2030)
Figure 56. Global Targeted Chemotherapy Drugs Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Targeted Chemotherapy Drugs by Application (2019-2030)
Figure 58. Global Revenue Market Share of Targeted Chemotherapy Drugs by Application (2019-2030)
Figure 59. Global Targeted Chemotherapy Drugs Price (US$/Unit) by Application (2019-2030)
Figure 60. Targeted Chemotherapy Drugs Value Chain
Figure 61. Targeted Chemotherapy Drugs Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
